MedTrace Logo

Different Doses of Vitamin D and T Regulatory Cells in Preterm Infants

NCT03793309 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2019-01-07

No results posted yet for this study

Summary

This study evaluate the effect of two different doses of vitamin D on T-regulatory cells in preterm infants. Half of the subjects receives 400 IU vitamin D and the other half receives 800 IU vitamin D.

Conditions

  • Prematurity
  • Immune Defect

Interventions

DRUG

Vitamin D

Oral vitamin D

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Lamiaa Mohsen, MD · Cairo University Children's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Max Age
28 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-09
Primary Completion
2017-12-11
Completion
2017-12-11

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03793309 on ClinicalTrials.gov